Trials / Completed
CompletedNCT05607186
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 59 (actual)
- Sponsor
- Singapore General Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a retrospective cohort study that aims to evaluate the correlation of magnetic resonance tumour regression grade (mrTRG) and pathological TRG (pTRG) of locally advanced rectal cancer after neoadjuvant long course chemoradiotherapy as well as the prognostic value of mrTRG on survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | neoadjuvant long course chemoradiotherapy | neoadjuvant long course chemoradiotherapy consist of radiosensitizing 5FU or capecitabine and 50.4 Gy in 28 fractions over 5 weeks |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2016-12-31
- Completion
- 2019-12-31
- First posted
- 2022-11-07
- Last updated
- 2022-11-07
Source: ClinicalTrials.gov record NCT05607186. Inclusion in this directory is not an endorsement.